Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine, Expert Review of Vaccines, vol.9, issue.12, pp.1385-13981471, 2010. ,
DOI : 10.1586/erv.10.141
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study, BMJ, vol.340, issue.may27 1, p.2649, 2010. ,
DOI : 10.1136/bmj.c2649
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial, Vaccine, vol.28, issue.7, pp.1740-1745, 2010. ,
DOI : 10.1016/j.vaccine.2009.12.014
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents, Vaccine, vol.29, issue.26, pp.4353-4361, 2011. ,
DOI : 10.1016/j.vaccine.2011.04.011
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers, Vaccine, vol.29, issue.2, pp.266-273, 2010. ,
DOI : 10.1016/j.vaccine.2010.10.038
Clinical evaluation of an AS03-adjuvanted pandemic influenza H1N1 2009 vaccine in children (Preliminary report), J Jap Pediatr Soc, vol.115, pp.578-584, 2011. ,
Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 infl uenza vaccine, Human Vaccines & Immunotherapeutics, vol.8, pp.1-11, 2012. ,
Safety and Cross???Reactive Immunogenicity of Candidate AS03???Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults, The Journal of Infectious Diseases, vol.201, issue.11, pp.1644-1653, 2010. ,
DOI : 10.1086/652701
Adjuvant System AS03 containing ??-tocopherol modulates innate immune response and leads to improved adaptive immunity, Vaccine, vol.29, issue.13, pp.2461-2473, 2011. ,
DOI : 10.1016/j.vaccine.2011.01.011
Immunogenicity and protective efficacy of influenza vaccination, Virus Research, vol.103, issue.1-2, pp.133-138, 2004. ,
DOI : 10.1016/j.virusres.2004.02.025
Antibody induction by influenza vaccines in the elderly: a review of the literature, Vaccine, vol.7, issue.5, pp.385-394, 1989. ,
DOI : 10.1016/0264-410X(89)90150-3
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons, Journal of Infectious Diseases, vol.206, issue.6, pp.811-820, 2012. ,
DOI : 10.1093/infdis/jis427
Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age, The Pediatric Infectious Disease Journal, vol.31, issue.8, pp.848-858, 2012. ,
DOI : 10.1097/INF.0b013e31825e6cd6
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis, BMJ, vol.346, issue.feb26 2, p.794, 2013. ,
DOI : 10.1136/bmj.f794
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland, PLoS ONE, vol.21, issue.3, p.33536, 2012. ,
DOI : 10.1371/journal.pone.0033536.t004
Atypical forms of Guillain-Barr?? syndrome and H1N1-influenza vaccination, Vaccine, vol.30, issue.22, pp.3251-3254, 2012. ,
DOI : 10.1016/j.vaccine.2012.03.013
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial, The Lancet Infectious Diseases, vol.11, issue.2, pp.91-101, 2011. ,
DOI : 10.1016/S1473-3099(10)70296-6
Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant, Journal of Infectious Diseases, vol.205, issue.5, pp.733-744, 2012. ,
DOI : 10.1093/infdis/jir641
-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older, Human Vaccines & Immunotherapeutics, vol.27, issue.8, pp.1119-1125, 2012. ,
DOI : 10.1016/j.vaccine.2010.12.125
URL : https://hal.archives-ouvertes.fr/in2p3-00186195
???Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age, Clinical Infectious Diseases, vol.51, issue.6, pp.3668-677, 2010. ,
DOI : 10.1086/655830